Nuclear Medicine/ Radiopharmaceuticals Market 2020 – Global Industry Analysis, Size, Market Demand, Regional Growth, Share, Trends, Opportunities and Forecast 2026

The global Nuclear Medicine/Radiopharmaceuticals Market size is projected to reach USD 9.67 billion by 2026. According to a report published by Fortune Business Insights, titled “Nuclear Medicine/Radiopharmaceuticals Market Size, Share & Industry Analysis, By Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), By Application (Neurology, Cardiology, Oncology, and Others), By End User (Hospitals & Clinics, Diagnostic Centres, and Others) and Regional Forecast, 2019-2026,” the market was valued at USD 4.86 billion in 2018. Driven by increasing number of successful clinical trials, the market will exhibit a CAGR of 9.2% from 2019-2026. Radiopharmaceuticals are substances that are used to diagnose specific medical problems or diseases. Increasing imaging capabilities and efficiencies have led to a wide product adoption across the world. Increasing number of successful clinical trials associated with radiopharmaceuticals will fuel the demand for the product. Recent drug application area discoveries have showcased promise for the companies operating in the market. Technological advancements in nuclear imaging and their applications in diagnosis of cancer and other serious diseases have opened up a huge potential for growth.

The report covers:

• Global Nuclear Medicine/ Radiopharmaceuticals Market trends, with detailed analysis on consumer trends & manufacturer trends.
• Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
• Key areas of investments identifying market opportunities and challenges in forecast timeframe.
• Competitive analysis of the industry players along with the overview on strategic management.
• Comprehensive company profiles of the major industry players.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nuclear-medicine-radiopharmaceuticals-market-101812

Leading Players operating in the Nuclear Medicine/ Radiopharmaceuticals Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Lantheus Medical Imaging, Inc.
• Cardinal Health
• Norgine B.V.
• Curium
• Advanced Accelerator Applications (Novartis AG)
• Bracco Diagnostic Inc.
• Jubilant Life Sciences Limited
• Bayer AG
• Eli Lilly and Company
• GE Healthcare (General Electric Company)

Driven by Increasing Number of Product Launches, Market to Expand at a High Rate

The increasing number of product launches has offered a wider scope for growth. The presence of several pipeline drugs will open up a potential for the growth of the market in the coming years. The increased investment has massively helped the development of these pipeline drugs. Increased emphasis on R&D of pipeline drugs has enabled the possibilities to explore the untapped potential that is carried by radiopharmaceuticals. In 2018, Norgine B.V. announced the launch of Lymphoseek, a radiopharmaceutical designed for oncological procedures. The report highlights new products, similar to Lymphoseek and gauges the impact of these products on the market.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/nuclear-medicine-radiopharmaceuticals-market-101812

North America to Witness Highest Growth; Growing Adoption of Nuclear Imaging to Aid Growth

The report segments the market on the basis of regional demographics into Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, North America will emerge dominant in the coming years. The advancements in nuclear imaging and increasing adoption in therapeutics has contributed to the growth of the market in North America. Increased awareness regarding the adverse effects of cancer and other serious diseases will create several growth opportunities for the companies operating in the regional market of North America.

Detailed Table of Content:

• Introduction
o Research Scope
o Market Segmentation
o Research Methodology
o Definitions and Assumptions
• Executive Summary
• Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
• Key Insights
o Installed Base of PET/PET-CT Scanners – For Key Countries, 2015 and 2018
o Installed Base of Gamma Cameras – for Key Countries, 2018
o PET/PET-CT Procedure Volume – for Key Countries, 2018
o Reimbursement Scenario in Key Countries
o New Product Launches
o Key Industry Developments
o Pipeline Analysis
• Global Nuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2015-2026
o Key Findings / Summary
o Market Analysis, Insights and Forecast – By Type
 Diagnostic Radiopharmaceuticals
• PET Radiopharmaceuticals
o FDG-PET/18F
o 68Ga
o 68Cu
o 11C
o Others
• SPECT Radiopharmaceuticals
o Technetium-99m
o Iodine-123
o Xenon-133
o Thallium-201
o Others
 Therapeutic Radiopharmaceuticals
o Market Analysis, Insights and Forecast – By Application
 Neurology
 Cardiology
 Oncology
 Others
o Market Analysis, Insights and Forecast – By End User
 Hospitals & Clinics
 Diagnostic Centers
 Others
o Market Analysis, Insights and Forecast – By Region
 North America
 Europe
 Asia Pacific
 Rest of the World

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/nuclear-medicine-radiopharmaceuticals-market-101812

Report Focus:

• Extensive product offerings
• Customer research services
• Robust research methodology
• Comprehensive reports
• Latest technological developments
• Value chain analysis
• Potential Nuclear Medicine/ Radiopharmaceuticals Market opportunities
• Growth dynamics
• Quality assurance
• Post-sales support
• Regular report updates

Reasons to Purchase this Report:

• Comprehensive analysis of the Nuclear Medicine/ Radiopharmaceuticals Market growth drivers, obstacles, opportunities, and other related challenges.
• Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
• Identifies market restraints and boosters.
• Identifies all the possible segments present in the market to aid organizations in strategic business planning.

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.